Obese Clinical Trial
Official title:
Attenuation of Interhepatic Fat and Hepatic Biomarkers With Exercise
| Verified date | January 2018 |
| Source | University of Missouri-Columbia |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Individuals with obesity and particular type 2 diabetes have abnormally high levels of fat in liver cells and are at increased risk for cardiovascular and liver-related mortality. Prior research has shown that caloric restriction, exercise, and behavior modification can help lower hepatic fat levels in these individuals. Additional research has also shown that exercise independent of weight loss can reduce hepatic fat content in obese humans. The current exercise guidelines do not specify what type or what intensity of exercise is required to induce such reductions in hepatic fat. Thus, the purpose for doing this study is to determine if there are differential effects on liver fat with 4 wk of high intensity intermittent exercise compared with continuous moderate exercise in obese individuals.
| Status | Completed |
| Enrollment | 57 |
| Est. completion date | June 1, 2017 |
| Est. primary completion date | June 1, 2017 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 21 Years to 60 Years |
| Eligibility |
Inclusion Criteria: - Overweight or obese with a body mass index between 30-45 kg/m2. - No known cardiovascular, kidney, or liver disease. - No extreme hypertension (>160 mm Hg systolic and/or > 100 mm Hg diastolic). - Not being treated with exogenous insulin. - No history of surgery for weight loss and weight stable for prior 3 months (weight change < 3 kg). - Non-exerciser (< 20 minutes of exercise 2 days per week). - Between 21-60 yr of age Exclusion Criteria: - History of alcohol use (> 20 g/day for males and > 10 g/day for females) - Kidney or liver disease. - Extreme hypertension >160 mm Hg systolic and/or > 100 mm Hg diastolic. - Waist measurement greater than 60" - Magnetic Resonance Spectroscopy scan with less than 5% of liver fat - A history of surgery for weight loss. - Exerciser (>20 minutes of exercise at least 2 days per week) - Pregnant or lactating - <21 or >60 yr of age |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Missouri | Columbia | Missouri |
| Lead Sponsor | Collaborator |
|---|---|
| University of Missouri-Columbia |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | blood measures of blood lipids (triglycerides, cholesterol, high density lipoproteins (HDL) ) | 6 weeks | ||
| Primary | percent of intrahepatic fat as measured by magnetic resonance spectroscopy | 6 weeks | ||
| Secondary | plasma cytokeratin 18 (ck18) units: (U/I) | 6 weeks |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04105075 -
COPD in Obese Patients
|
||
| Completed |
NCT04099654 -
The Effect of Core Stabilization Exercise Program in Obese Subjects Awaiting Bariatric Surgery
|
N/A | |
| Recruiting |
NCT05857150 -
Exercise Response in Humans With Obesity
|
||
| Completed |
NCT03532672 -
Early Effect of Fasting on Metabolic, Inflammatory, and Behavioral Responses in Females With and Without Obesity
|
N/A | |
| Completed |
NCT02086448 -
Sleep Disordered Breathing, Obesity and Pregnancy Study (SOAP)
|
N/A | |
| Completed |
NCT02618486 -
The Effects of Obesity on Non Surgical Periodontal Therapy
|
N/A | |
| Completed |
NCT01724502 -
Mitochondrial Dysfunction in Diabetes
|
N/A | |
| Completed |
NCT01724515 -
PGC-1 and Mitochondrial Dysfunction in Diabetes
|
N/A | |
| Active, not recruiting |
NCT01634204 -
Efficacy of a Web-based Weight Loss Program
|
Phase 2 | |
| Completed |
NCT01479933 -
Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes
|
N/A | |
| Completed |
NCT01421589 -
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
|
N/A | |
| Completed |
NCT01467817 -
Obesity/Overweight in Persons With Early and Chronic Spinal Cord Injury (SCI)
|
N/A | |
| Completed |
NCT03528304 -
Native Women's Wellness: Contingency Management for Tobacco Cessation and Weight Loss
|
N/A | |
| Completed |
NCT01726647 -
Metabolism Associated With Abdominal Fat Mass Distribution
|
N/A | |
| Active, not recruiting |
NCT02125149 -
The Expecting Study
|
N/A | |
| Completed |
NCT05737927 -
Pharmacodynamics and Pharmacokinetics of Different Glucose Bead Formulations in Obese Healthy Subjects
|
Phase 1 | |
| Completed |
NCT05433506 -
Safety and Pharmacokinetics of HU6
|
Phase 1 | |
| Completed |
NCT02871882 -
Ox Bile- Conjugated Bile Acids Sodium in Type II Diabetes Mellitus
|
Phase 2 | |
| Completed |
NCT03298464 -
Study of NGM313 in Obese Participants
|
Phase 1 | |
| Completed |
NCT05061173 -
Comparison of Aerobic, Resistance, and Combined Training in Overweight/Obese Hypertensive Adults
|
N/A |